Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,099
datasets available to search
ShareScore release 0.9.0
Dataset results
3,099 results for “Immunotherapy”
Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines
ClinicalTrials.gov study NCT03481816. IPD Sharing: NO. Countries: 1. Publications: 1.
Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT03081689. IPD Sharing: NO. Countries: 1. Publications: 6.
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
ClinicalTrials.gov study NCT03462030. IPD Sharing: Not stated. Countries: 1. Publications: 33.
Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Mela
ClinicalTrials.gov study NCT00096382. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants With Solid Cancers That Are Advanced or Have Spread
ClinicalTrials.gov study NCT03446040. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma
ClinicalTrials.gov study NCT02511132. IPD Sharing: NO. Countries: 1. Publications: 4.
Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy
ClinicalTrials.gov study NCT03904108. IPD Sharing: NO. Countries: 1. Publications: 24.
Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT02111863. IPD Sharing: NO. Countries: 1. Publications: 3.
PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer
ClinicalTrials.gov study NCT03179410. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
ClinicalTrials.gov study NCT04287868. IPD Sharing: YES. Countries: 1. Publications: 1.
Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence
ClinicalTrials.gov study NCT04410445. IPD Sharing: UNDECIDED. Countries: 17. Publications: 1.
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
ClinicalTrials.gov study NCT03914612. IPD Sharing: YES. Countries: 5. Publications: 3.
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
ClinicalTrials.gov study NCT04526730. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
ClinicalTrials.gov study NCT01904604. IPD Sharing: YES. Countries: 1. Publications: 4.
Oral Immunotherapy for Peanut and Mammalian Meat Allergies
ClinicalTrials.gov study NCT02350660. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT01993719. IPD Sharing: YES. Countries: 1. Publications: 2.
Allergy Immunotherapy for the Reduction of Asthma
ClinicalTrials.gov study NCT01028560. IPD Sharing: Not stated. Countries: 1. Publications: 6.
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma
ClinicalTrials.gov study NCT02062359. IPD Sharing: NO. Countries: 1. Publications: 3.
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC
ClinicalTrials.gov study NCT03164772. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer
ClinicalTrials.gov study NCT01220128. IPD Sharing: YES. Countries: 7. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.